Treating ‘osteoporosis’: a near miss in an unusual case of FGF-23-mediated hypophosphataemic osteomalacia
We present the case of a 60-year-old female who developed repeated atraumatic stress fractures. She was initially diagnosed with osteoporosis based on her dual-energy X-ray absorptiometry (DXA) scan bone mineral density (BMD) T-scores and started on denosumab therapy. Secondary osteoporosis screen r...
Main Authors: | Mike Lin, Kirtan Ganda |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2022-11-01
|
Series: | Endocrinology, Diabetes & Metabolism Case Reports |
Online Access: | https://edm.bioscientifica.com/view/journals/edm/2022/1/EDM22-0300.xml |
Similar Items
-
Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia
by: Amarnani, R, et al.
Published: (2020) -
Long-term iron polymaltose infusions associated with hypophosphataemic osteomalacia: a report of two cases and review of the literature
by: Ramy H. Bishay, et al.
Published: (2017-01-01) -
Selective blood sampling for FGF-23 in tumor-induced osteomalacia
by: Hans-Christof Schober, et al.
Published: (2017-10-01) -
Hypophosphatemic osteomalacia induced by FGF23-secreting tumor of the left femur
by: S. S. Rodionova, et al.
Published: (2019-12-01) -
Phosphopenic form of osteomalacia in a patient with FGF23 producing tumor
by: A. S. Pushkareva, et al.
Published: (2022-05-01)